Industry News

The La Jolla Institute of Allergy and Immunology contracted Bilbro Construction Co. for remodeling and tenant improvement of 1,500 sf in an occupied biomedical lab facility. The $250,000 project was designed by Architects Delawie Wilkes Rodriguez Barker and engineered by TKG Consulting Engineers.

Transkaryotic Therapies Inc. is building a 185,000-sf headquarters and state-of-the-art laboratory and research facility in an MIT-owned building in Cambridge. The $65 million project, developed by Barr & Barr Inc., involves renovating the existing building, including restoration of the historical building's 150-year-old facade.

The Cancer Therapy and Research Center has completed a 20,000-sf expansion of its Institute for Drug Development. Consolidating basic and translational research labs, the facility will focus on developing new cancer treatment therapies. The expansion is funded by a $35 million capital campaign that will also endow the IDD senior scientific chairs.

Bethesda-based Coagulation Diagnostics Inc. moved into a new lab facility at the Maryland Technology Development Center in Rockville on May 1.  The biotech firm, maker of commercialized diagnostic tests for cardiovascular disease, will retain its Bethesda office space while expanding its R&D operations.

Sandia/California National Laboratories plans to begin construction on the Distributed Information Systems Laboratory in April 2002. The $35.5-million, 70,400-sf R&D facility will house 130 scientists from a variety of fields collaborating on improving nuclear weapons monitoring and testing, which is carried out by computer simulations. Dekker/Perich/Sabatini of Albuquerque, N.M., was awarded the $1,562,000 design contract for the project.